GASTRIC (STOMACH) CANCER

This study is testing whether adding a drug called fruquintinib to standard chemotherapy and trastuzumab can help control advanced HER2-positive stomach or gastroesophageal junction cancer. It is for people who have not had prior treatment for their metastatic disease. The goal i…

This study tests a new drug called TCC1727 combined with other cancer treatments (benmelstobart, olaparib, or topotecan) for people with advanced solid tumors that have stopped responding to standard therapy. The goal is to find the safest dose and see if the combination can shri…

This study tests a new treatment called RAK cell therapy for people with advanced stomach cancer that has spread or come back after standard treatments. The therapy uses immune cells from donated umbilical cord blood to help fight the cancer. The goal is to see if it can help pat…

This study looks at people with esophageal or stomach cancer that has spread to only a few places (oligometastases). All participants get 4 months of standard drug therapy, then are randomly assigned to either have local treatment (surgery or radiation) right away or after anothe…

This study is testing a new way to screen for stomach cancer using a stool sample and a short questionnaire. Researchers want to see if this simple, non-invasive method can find cancer earlier than current approaches. About 15,000 adults aged 40 and older will take part, and all …

This study tests whether the drug riluzole can prevent memory and thinking problems (often called 'chemo brain') in people receiving chemotherapy for various cancers. About 24 adults with breast, lung, or other cancers will receive either riluzole or a placebo during their chemo.…

This study tests whether using virtual reality (VR) can reduce severe belly pain in people with digestive tract cancers. 360 participants will be split into three groups: one using skills-based VR, one using distraction VR, and a sham control group. Researchers will track pain, a…

This study follows 3000 adults aged 40 and older who carry H. pylori bacteria in their stomach. Researchers want to see if people with certain high-risk subtypes of the bacteria are more likely to develop stomach cancer or precancerous changes over 3 to 10 years. Participants wil…

This study collects tissue and blood samples from people with stomach or esophageal cancer, as well as those at high inherited risk, to learn how genes and proteins contribute to these cancers. Researchers aim to better understand the disease, not to test a new treatment. About 1…

This study aims to describe the characteristics of 1,000 people with gastric cancer in Algeria, including their demographics, risk factors, symptoms, and how they are diagnosed and treated. By collecting this information, researchers hope to better understand the disease and impr…